Ketamine treatment offers an alternative for people with severe depression or chronic pain who have not responded to standard medications. Candidates include those with treatment-resistant depression, conditions like CRPS, or recurring suicidal thoughts.
Most patients have already tried at least two antidepressants or multiple pain management approaches without success. A full medical history is required because issues like uncontrolled blood pressure or active substance use increase treatment risk.
Who is a candidate for ketamine treatment? A psychiatric evaluation and physical exam are completed before any session. Only a qualified physician can determine if a patient meets the criteria for therapy based on their health and treatment history.
What Ketamine Treatment Is Used For
Ketamine treatment serves specific medical conditions where standard therapies have failed. The primary use cases fall into two categories: psychiatric disorders and chronic pain syndromes.
- Treatment Resistant Depression
Treatment resistant depression defines the most common reason clinicians prescribe ketamine. A patient meets this label when two or more antidepressants at adequate doses and durations produce no meaningful symptom relief.
Ketamine targets different brain receptors than standard antidepressants. This distinct mechanism allows it to work for patients who did not respond to SSRIs or SNRIs.
- Severe Anxiety and Post Traumatic Stress
Severe anxiety disorders including generalized anxiety and social anxiety show response to ketamine in clinical studies. Post traumatic stress or PTSD also responds, particularly when trauma symptoms persist despite years of talk therapy.
Patients with constant hyperarousal or flashbacks may experience rapid symptom reduction. A single ketamine session can interrupt the cycle of fear memory consolidation.
- Active Suicidal Thoughts
Active suicidal thoughts represent a unique indication for ketamine treatment. A patient with immediate risk of self harm can receive ketamine to lower that risk within hours rather than weeks.
Emergency room protocols now include ketamine for acute suicidality. This use requires close medical supervision and a follow up safety plan.
- Chronic Pain Conditions
Chronic pain conditions like complex regional pain syndrome or CRPS respond well to ketamine infusion. Fibromyalgia and neuropathic pain also fall into this category when nerve blocks and opioids have failed.
Ketamine blocks NMDA receptors in the spinal cord, which interrupts pain signal transmission. A patient with CRPS may receive a multi day inpatient infusion protocol for extended relief.
- People Who Have Tried Standard Treatments First
Ketamine treatment is not a first line therapy for any condition. A patient must demonstrate failure of standard approaches before a doctor considers ketamine appropriate.
- Failed Antidepressants and Mood Stabilizers
Failed antidepressant trials define the minimum requirement for ketamine consideration in depression. A patient typically needs two different medications from two different drug classes taken for at least six weeks each without adequate response.
Mood stabilizers for bipolar depression also count as prior treatment failures. Lithium, valproate, or lamotrigine that produce no symptom improvement put a patient closer to ketamine candidacy.
- Incomplete Response to Talk Therapy
Talk therapy alone or with medications often provides incomplete relief for severe anxiety and PTSD. A patient who completes twelve weeks of cognitive behavioral therapy but still cannot leave the house may qualify for ketamine.
Exposure therapy for PTSD that fails to reduce flashbacks or hypervigilance represents another treatment failure. Ketamine can then serve as an adjunct to restart or enhance the therapy process.
- Unsuccessful Pain Management Protocols
Unsuccessful pain management protocols include nerve blocks, physical therapy, and opioid medications.
- A patient with CRPS who receives three nerve blocks with no lasting pain reduction has exhausted standard options.
- Anticonvulsants like gabapentin or pregabalin that fail to control neuropathic pain also count as prior treatment failures.
Ketamine becomes an option when a patient tries these first line agents and still reports pain above four on a zero to ten scale.
- People Who Are Medically Stable
Ketamine treatment places stress on the cardiovascular system. A patient must achieve medical stability across several organ systems before any clinic accepts them for therapy.
- Controlled Blood Pressure
Controlled blood pressure stands as a non negotiable requirement for ketamine infusion. A patient with readings above 140/90 mmHg even after antihypertensive medications faces too high a risk of stroke or cardiac event during treatment.
Ketamine can raise blood pressure by twenty to thirty points within minutes of administration. A patient whose baseline sits at 130/80 mmHg may still require additional blood pressure medication before or during the infusion.
- No Unstable Heart Conditions
Unstable heart conditions disqualify a patient from ketamine treatment outright. A patient with recent heart attack within six months, uncontrolled arrhythmia, or decompensated heart failure cannot safely receive this therapy.
Stable heart conditions like well managed atrial fibrillation or a pacemaker require cardiology clearance first. A patient with a history of bypass surgery from five years ago and no current chest pain may receive approval after an electrocardiogram.
- Treated Thyroid Problems
Treated thyroid problems allow ketamine treatment to proceed without extra risk. A patient with hyperthyroidism or hypothyroidism must show normal thyroid hormone levels on medication for at least three months.
Untreated or poorly managed thyroid disease can magnify ketamine effects on heart rate and blood pressure. A patient with a thyroid stimulating hormone level outside the normal range needs endocrinology follow up before any ketamine session.
- Recent Physical Exam Documentation
Recent physical exam documentation within thirty days of the first ketamine session protects patient safety. A doctor must listen to the heart and lungs, check reflexes, and review medication lists for potential interactions.
The physical exam also screens for undiagnosed conditions like aortic stenosis or glaucoma. A patient with an abnormal finding needs specialist clearance before ketamine becomes a safe option.
- People Without Certain Active Addictions
Ketamine has a history of misuse as a recreational drug. A patient with certain active substance use disorders faces higher risks of addiction, adverse effects, or treatment failure.
- Active Alcohol Use Disorder
Active alcohol use disorder creates dangerous interactions with ketamine. A patient who drinks heavily daily may experience respiratory depression or severe sedation when ketamine is added.
Alcohol also reduces the antidepressant effect of ketamine over time. A patient who stops drinking for at least two weeks before treatment has a better chance of lasting symptom relief.
- Active Stimulant or Opioid Abuse
Active stimulant or opioid abuse raises the risk of heart complications during ketamine infusion. A patient using cocaine, methamphetamine, or non prescribed opioids can experience sudden blood pressure spikes or arrhythmias when ketamine enters the system.
Clinics require a negative urine drug screen before each ketamine session. A patient who tests positive for these substances receives a treatment hold and a referral to addiction medicine.
- Past Versus Current Use
Past substance use does not automatically disqualify a patient from ketamine treatment. A patient with five years of sobriety or a completed rehabilitation program can safely receive ketamine under medical supervision.
Current use means active use within the past thirty days for most clinic protocols. A patient who used cannabis once three months ago but has no pattern of abuse may still qualify for treatment.
- Honest Disclosure to the Doctor
Honest disclosure about all substance use allows the doctor to make a safe decision. A patient who hides alcohol or drug use risks a seizure, psychosis, or cardiac arrest during the infusion.
Clinicians do not report past substance use to law enforcement. A patient who shares a full history receives a safer ketamine protocol with adjusted doses or additional monitoring.
- People Who Have a Psychiatrist or Doctor Involved
Ketamine is not a standalone cure. A patient needs an existing doctor or therapist to manage their overall care before, during, and after the treatment course.
- Ongoing Psychiatric Care
Ongoing psychiatric care provides stability when ketamine effects wear off between sessions. A patient who sees a psychiatrist every four to six weeks for medication management can adjust other drugs as the ketamine protocol progresses.
Ketamine infusions typically occur in a series of six over two to three weeks. A patient without a psychiatrist to monitor mood changes may experience a relapse after the final infusion.
- Regular Therapy as a Support
Regular therapy helps a patient integrate the psychological effects of a ketamine session. A therapist can process any difficult emotions or memories that surface during the dissociative experience.
Ketamine opens a short window of brain plasticity that lasts twenty four to seventy two hours. A patient who attends therapy within that window gains more lasting benefit than a patient who does not.
- Medical Follow Up Between Infusions
Medical follow up between infusions catches side effects or complications early. A patient needs a primary care doctor to check blood pressure, liver function, and bladder symptoms at regular intervals.
Urinary symptoms like frequency, urgency, or pain require immediate reporting. A patient without a doctor to call for these symptoms risks permanent bladder damage from repeated ketamine use.
- Clinic Safety Checks Before Each Session
Clinic safety checks before each session include vital signs and a brief mental health questionnaire. Report any new medication, illness, or substance use since the last visit.
The doctor reviews suicidal thoughts or self harm urges at every check in. A patient who shows worsening depression or new psychosis receives a treatment pause and a referral back to their psychiatrist.
Who Is Usually Not a Candidate
Ketamine treatment carries real risks for certain patient groups. A doctor must screen for these conditions before any infusion begins.
- Active Psychosis or Mania
Active psychosis or mania can worsen dramatically with ketamine administration. A patient who hears voices, holds fixed false beliefs, or experiences grandiose thoughts may enter a full psychotic break after a single session.
Manic episodes with rapid speech, reckless behavior, or no need for sleep also contraindicate ketamine. A patient with bipolar I disorder who is not on a mood stabilizer should try standard mood regulation first.
- Personal History of Uncontrolled Seizures
Personal history of uncontrolled seizures presents a serious danger during ketamine infusion. A patient with epilepsy who has a seizure every week faces a higher chance of seizure activity during or right after treatment.
Ketamine can lower the seizure threshold in susceptible individuals. A patient whose seizures are well controlled on medication for at least one year may still receive ketamine but only with a neurologist's written approval.
- Pregnancy or Breastfeeding
Pregnancy excludes a patient from ketamine treatment due to unknown effects on fetal brain development. Animal studies show risks to the developing nervous system, though human data remains limited.
Breastfeeding also disqualifies a patient because ketamine passes into breast milk. A patient who plans pregnancy should complete ketamine treatment and wait a washout period before conceiving.
- Very High Unmanaged Blood Pressure
Very high unmanaged blood pressure creates a risk of hypertensive crisis or brain bleed. A patient with baseline readings above 160/100 mmHg despite three or more blood pressure medications cannot safely receive ketamine.
Even a single ketamine infusion can push that patient into stroke territory. A patient who lowers blood pressure into the controlled range for three consecutive months may become a candidate later.
Conclusion
Ketamine treatment helps a specific group of patients who have exhausted standard options. A good candidate has treatment resistant depression, severe PTSD, chronic pain like CRPS, or recurring suicidal thoughts with no response to prior therapies.
Medical stability and honesty about substance use determine safety more than any other factor. A patient with controlled blood pressure, no active addiction, and a regular psychiatrist or therapist can proceed with low risk.
Not every suffering patient qualifies for ketamine. A full medical and psychiatric evaluation from a knowledgeable doctor provides the only reliable answer for any individual.